1,330,000 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Acquired by Sachem Head Capital Management LP

Sachem Head Capital Management LP bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,330,000 shares of the company’s stock, valued at approximately $52,734,000. Acadia Healthcare accounts for about 2.9% of Sachem Head Capital Management LP’s holdings, making the stock its 12th largest position.

A number of other large investors also recently modified their holdings of the company. Treasurer of the State of North Carolina increased its position in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock valued at $1,586,000 after purchasing an additional 250 shares during the last quarter. Nisa Investment Advisors LLC increased its position in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Coldstream Capital Management Inc. increased its position in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock valued at $257,000 after purchasing an additional 303 shares during the last quarter. Covestor Ltd increased its position in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after purchasing an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock valued at $549,000 after purchasing an additional 325 shares during the last quarter.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Barclays dropped their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Mizuho cut their target price on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, Guggenheim began coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $47.94.

Acadia Healthcare Stock Up 2.0%

Shares of NASDAQ:ACHC opened at $26.15 on Friday. The stock has a market cap of $2.41 billion, a P/E ratio of 8.57, a P/E/G ratio of 1.46 and a beta of 1.01. The firm has a fifty day moving average price of $26.19 and a 200 day moving average price of $35.66. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.84 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.